🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

How do we convince non-ID folks that IV-PO step down therapy is OK? Nico Cortes-Penfield MD FACP FIDSA 🦴💊 recs to have a champion to build rapport & trust. And make sure the whole ID group is on the same page - recs should not change based on who is on service! #IDWeek2023 #IDTwitter

1/8 Preview of revised IDSA Complicated UTI Guidelines, including simpler definition ("infection beyond the bladder"). Men CAN have an uncomplicated UTI.

Had a great time at #IDWeek2023… so nice catching up with everyone & loved seeing SIDP represent! Excited to take home a little #SIDP2023 bracelet as a souvenir! #BestBuggies

Thanks HDSI UChicago and UChicago Medicine! We have a great team, excited to get started on this important work! 👏🏼 Let’s clean up these allergies! @chicagoabx

Open House Sign-Ups are LIVE! Come catch us on Nov 16 or Nov 28 evening to talk about our residency programs! #TwitteRx #PharmRes uchicagopharmacyresidency.org/book-online

‼️Did you know the Joint Statement is now open access?⚠️ Thanks everyone for an awesome #AMSRxChat! ASHP & SIDP

Have you read the updated IDSA diabetic foot infxn guideline? Radhika Polisetty IDPharmD, FIDSA reviews some of the updates! 🛑 Don’t treat uninflected ulcers 🦠 Target Gram positives if no prior treatment ✋ Hold the empiric Pseudomonas coverage #IDTwitter #TwitteRx

Latest literature shows some pneumonias can be treated for as low as 3 days! @AlisonKLew reviews the literature. Have you incorporated this into your practice? #IDtwitter @TwitteRx

Looking for an ID PGY2 residency program? Check us out UChicago Medicine Pharmacy Residency Programs! #TwitteRx ✅ Interesting & challenging cases ✅ Academic medical center ✅ Immunocompromised pts ✅ Many ID Pharm preceptors ✅ Great physicians ✅ Many PGY1 & other PGY2 co-resies ✅ Fun city w/ great food

Next up is our PGY2 Infectious Diseases Pharmacy Resident, Jessica Ni! 🦠 💊 A little about our PGY2 ID program: • Daily multidisciplinary rounds on the ID consult services provide endless learning and teaching opportunities… #PharmRes #TwitteRx @chicagoabx

From Cynthia Nguyen Rachel Baccile @AlisonKLew @JenCPisano @Natasha_Pettit: Newly published study finds vancomycin surgical prophylaxis only necessary in patients previously colonized or infected with MRSA and those undergoing hip and knee replacement. bit.ly/3vNJSdI

We're hiring! 👀 Check out this opportunity to work with SIDP! SIDP is seeking highly skilled applicants for a Grants Coordinator position! For more information, check out our job listing! buff.ly/485yCa3

Cefepime/enmetazobactam (Exblifep) approved by U.S. FDA yesterday for cUTI & pyelo in adults. Primarily restores cefepime against ESBLs (CTX-M, SHV, TEM) w/ other benefits of cefepime (eg AmpC stability). Not active against KPC, MBLs, OXAs though. #IDTwitter #TwitteRx

Join Cynthia Nguyen for our #OncologySymposia. This session discusses integrating the latest scientific data and developments in COVID-19 prevention into optimized management approaches for cancer patients. bit.ly/4aAhkCR

Nice study demonstrating reduced incidence of new Gram-negative resistance longitudinally in hospitalized patients with sepsis who had their antibiotic de-escalated to something less broad spectrum. academic.oup.com/cid/advance-ar…

Due to supply disruptions, the U.S. FDA recommends laboratories and health care providers conserve the supply of BD BACTEC blood culture media bottles for patients at highest risk. Learn more in our Letter to Health Care Providers: fda.gov/medical-device…

Consumer Reports found plasticizers linked to a range of health harms in 99% of the food tested! It's time for action to protect public health. Sign the Consumer Reports Advocacy petition asking the U.S. FDA to ban plasticizers in our food. action.consumerreports.org/nb-20230104-fd…

‼️Recent publication from some of our very own ID PRN members 💯 IV to PO transitions in Strep bacteremia resulted in similar rates of clinical success (absence of infection/mortality at 90 days). IV 94.6% and PO 94.4% (P=0.946) 💊⚕️#idx #idxposts academic.oup.com/ofid/article/1…

3 daily rants in one week? A new record! It's a fair question. And the answer is, no. Even in immune suppressed patients there is no evidence that cidal vs. static means anything. Why?